ACHC
Acadia Healthcare Company, Inc.
ACHC lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
ACHC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Weak |
ACHC's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
ACHC PE Valuation
ACHC has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
ACHC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
ACHC has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
ACHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.02 | — |
| Q3 2026 | -$12.43 | -1153% |
| Q2 2026 | -$12.41 | -916% |
| Q1 2026 | -$12.20 | -698% |
| Q4 2025 | -$12.16 | -537% |
| Q3 2025 | $1.18 | -61% |
| Q2 2025 | $1.52 | +$1.59 |
| Q1 2025 | $2.04 | +$2.17 |
| Q4 2024 | $2.78 | +$3.02 |
ACHC has swung to a loss: it lost $12.43 per share over the past year, after a profit the year before.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over ACHC on earnings, with more consistent year-over-year improvement.
ACHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $895.3M | +5.1% |
| Q2 2026 | $865.8M | -0.4% |
| Q1 2026 | $828.8M | +7.6% |
| Q4 2025 | $821.5M | +6.1% |
| Q3 2025 | $851.6M | +4.4% |
| Q2 2025 | $869.2M | +9.2% |
| Q1 2025 | $770.5M | +0.3% |
| Q4 2024 | $774.2M | +4.2% |
ACHC's revenue is growing: $895M last quarter, up 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | +1.6 points |
| Q2 2026 | 2.5% | -3.2 points |
| Q1 2026 | 1.3% | -0.4 points |
| Q4 2025 | -142% | -147 points |
| Q3 2025 | 4.7% | -7.4 points |
| Q2 2025 | 5.8% | -7.6 points |
| Q1 2025 | 1.8% | -11 points |
| Q4 2024 | 4.9% | -5.9 points |
ACHC has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over ACHC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
ACHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $47.1M | +$110.2M |
| Q2 2026 | $123.5M | +$157.8M |
| Q1 2026 | -$15M | +$148.1M |
| Q4 2025 | -$179.5M | -$92.7M |
| Q3 2025 | -$63M | -$35.9M |
| Q2 2025 | -$34.2M | -303% |
| Q1 2025 | -$163.2M | +$300.5M |
| Q4 2024 | -$86.8M | -$64.4M |
ACHC has burned cash in six of the last eight quarters: −$24M over the past year, against −$347M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over ACHC on cash generation, producing positive trailing cash flow while its opponent burns cash.
ACHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +372K shares |
| 1 year | +1.3% | +1.2M shares |
| 3 years | +0.6% | +578K shares |
| 5 years | +0.9% | +857K shares |
| Available history | +4.5% | +3.9M shares |
ACHC has 92M diluted shares, up 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $3.2M |
| Q1 2025 | $46.9M |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over ACHC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
ACHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 6.8x | High |
| Q2 2025 | 5.7x | High |
| Q1 2025 | 5.1x | High |
| Q4 2024 | 3.8x | Elevated |
| Q3 2024 | 3.4x | Elevated |
| Q2 2024 | 12.7x | High |
| Q1 2024 | 14.2x | High |
| Q4 2023 | 11.9x | High |
ACHC's net debt is about 6.8 years of its operating earnings (EBITDA), up from 3.4 years a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
ACHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.3 | Overbought |
| Stochastic | 70.2 | Neutral |
ACHC's weekly RSI is 70 (overbought) and its Stochastic is 70 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
ACHC PE vs Healthcare Sector
| Metric | ACHC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ACHC has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
ACHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.5 | 20% above |
| 20 week MA | $30.9 | 23% above |
| 50 week MA | $24.8 | 52% above |
| 100 week MA | $25.9 | 46% above |
| 200 week MA | $48.6 | 22% below |
ACHC has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
ACHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $33.0 | $49.3 | +49% |
| 2021 | $49.3 | $59.1 | +20% |
| 2022 | $59.1 | $83.0 | +40% |
| 2023 | $83.0 | $77.8 | -6.3% |
| 2024 | $77.8 | $38.0 | -51% |
| 2025 | $38.0 | $14.7 | -61% |
| 2026 YTD | $14.7 | $37.8 | +157% |
ACHC has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.